CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician's Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT02562443
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:58.807435+00:00
Published At: 2022-09-26T00:00:00+00:00
Record Updated At: 2022-09-26
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Myelodysplastic Syndrome", "MDS", "Refractory Anemia With Excess Blasts", "RAEB"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-09-26"
protocolSection.identificationModule.nctId: "NCT02562443"
protocolSection.identificationModule.officialTitle: "A Phase III, International, Randomized, Controlled Study of Rigosertib Versus Physician\u0027s Choice of Treatment in Patients With Myelodysplastic Syndrome After Failure of a Hypomethylating Agent"
protocolSection.statusModule.overallStatus: "TERMINATED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.